Latest Insider Transactions at Procter & Gamble CO (PG)
This section provides a real-time view of insider transactions for Procter & Gamble CO (PG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PROCTER & GAMBLE Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PROCTER & GAMBLE Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
5,297
-8.78%
|
$619,749
$117.49 P/Share
|
|
Feb 27
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Indirect |
633
-6.24%
|
$74,061
$117.49 P/Share
|
|
Feb 27
2020
|
R. Alexandra Keith CEO - Beauty |
SELL
Open market or private sale
|
Direct |
2,343
-4.93%
|
$274,131
$117.49 P/Share
|
|
Feb 27
2020
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Open market or private sale
|
Direct |
2,687
-3.17%
|
$314,379
$117.49 P/Share
|
|
Feb 27
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
688
-8.85%
|
$80,496
$117.49 P/Share
|
|
Feb 27
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
3,451
-2.67%
|
$403,767
$117.49 P/Share
|
|
Feb 27
2020
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Open market or private sale
|
Direct |
2,738
-4.87%
|
$320,346
$117.49 P/Share
|
|
Feb 21
2020
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-80.84%
|
$1,270,000
$127.41 P/Share
|
|
Feb 21
2020
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.7%
|
$630,000
$63.05 P/Share
|
|
Feb 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Open market or private sale
|
Direct |
19,023
-46.15%
|
$2,396,898
$126.0 P/Share
|
|
Feb 21
2020
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,023
+31.58%
|
$1,274,541
$67.52 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Indirect |
19,077
-71.05%
|
$2,422,779
$127.32 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
19,077
+41.54%
|
$1,449,852
$76.18 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
127,987
-49.72%
|
$16,254,349
$127.31 P/Share
|
|
Feb 21
2020
|
Jon R Moeller Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
127,987
+33.21%
|
$9,727,012
$76.18 P/Share
|
|
Feb 21
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
74,520
-24.76%
|
$9,464,040
$127.3 P/Share
|
|
Feb 21
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
74,520
+19.85%
|
$5,887,080
$79.05 P/Share
|
|
Feb 21
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,000
-51.19%
|
$381,000
$127.75 P/Share
|
|
Feb 21
2020
|
Peltz Nelson Director |
SELL
Other acquisition or disposition
|
Indirect |
1,006,112
-3.13%
|
$126,770,112
$126.7 P/Share
|
|
Jan 28
2020
|
Carolyn M Tastad CEO - Health Care |
SELL
Open market or private sale
|
Direct |
37,385
-22.31%
|
$4,710,510
$126.28 P/Share
|
|
Jan 28
2020
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
37,385
+17.64%
|
$2,916,030
$78.86 P/Share
|
|
Jan 27
2020
|
David S Taylor Executive Chairman |
SELL
Open market or private sale
|
Direct |
58,297
-20.52%
|
$7,287,125
$125.93 P/Share
|
|
Jan 27
2020
|
David S Taylor Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
58,297
+17.03%
|
$4,430,572
$76.18 P/Share
|
|
Jan 24
2020
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
3,000
-43.76%
|
$378,000
$126.5 P/Share
|
|
Dec 19
2019
|
Gary A Coombe CEO - Grooming |
SELL
Bona fide gift
|
Direct |
323
-3.39%
|
-
|
|
Dec 10
2019
|
W James Mcnerney Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
322
+0.4%
|
-
|
|
Dec 10
2019
|
Terry J Lundgren Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+1.12%
|
-
|
|
Dec 10
2019
|
Francis S Blake Director |
BUY
Grant, award, or other acquisition
|
Direct |
242
+1.43%
|
-
|
|
Dec 10
2019
|
Scott D Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
136
+0.16%
|
-
|
|
Dec 10
2019
|
Joseph Jimenez Director |
BUY
Grant, award, or other acquisition
|
Direct |
388
+2.04%
|
-
|
|
Dec 10
2019
|
Angela F Braly Director |
BUY
Grant, award, or other acquisition
|
Direct |
282
+0.66%
|
-
|
|
Nov 27
2019
|
Carolyn M Tastad CEO - Health Care |
SELL
Bona fide gift
|
Direct |
335
-0.55%
|
-
|
|
Nov 26
2019
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Open market or private sale
|
Direct |
1,729
-20.14%
|
$210,938
$122.0 P/Share
|
|
Nov 20
2019
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-1.13%
|
$61,710
$121.95 P/Share
|
|
Nov 20
2019
|
Kathleen B Fish Chf Rsch, Dev & Innv Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62
+0.28%
|
$7,502
$121.95 P/Share
|
|
Nov 20
2019
|
Marc S. Pritchard Chief Brand Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.13%
|
$17,182
$121.95 P/Share
|
|
Nov 20
2019
|
Marc S. Pritchard Chief Brand Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
142
+0.13%
|
$17,182
$121.95 P/Share
|
|
Nov 20
2019
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25
-0.29%
|
$3,025
$121.95 P/Share
|
|
Nov 20
2019
|
Ma. Fatima Francisco CEO - Baby, Fem & Family Care |
BUY
Exercise of conversion of derivative security
|
Direct |
25
+0.29%
|
$3,025
$121.95 P/Share
|
|
Nov 20
2019
|
Deborah P Majoras Chief Legal Officer & Secy |
SELL
Payment of exercise price or tax liability
|
Direct |
621
-0.37%
|
$75,141
$121.95 P/Share
|
|
Nov 20
2019
|
Deborah P Majoras Chief Legal Officer & Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
79
+0.07%
|
$9,559
$121.95 P/Share
|
|
Nov 20
2019
|
Shailesh Jejurikar Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15
-0.63%
|
$1,815
$121.95 P/Share
|
|
Nov 20
2019
|
Shailesh Jejurikar Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15
+0.63%
|
$1,815
$121.95 P/Share
|
|
Nov 20
2019
|
Mary Theresa Grabowski Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40
-2.09%
|
$4,840
$121.95 P/Share
|
|
Nov 20
2019
|
Mary Theresa Grabowski Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40
+2.05%
|
$4,840
$121.95 P/Share
|
|
Nov 20
2019
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-0.4%
|
$82,401
$121.95 P/Share
|
|
Nov 20
2019
|
Mary Lynn Ferguson Mchugh CEO - Family Care & P&G Ventur |
BUY
Exercise of conversion of derivative security
|
Direct |
84
+0.1%
|
$10,164
$121.95 P/Share
|
|
Nov 20
2019
|
Carolyn M Tastad CEO - Health Care |
SELL
Payment of exercise price or tax liability
|
Direct |
943
-0.77%
|
$114,103
$121.95 P/Share
|
|
Nov 20
2019
|
Carolyn M Tastad CEO - Health Care |
BUY
Exercise of conversion of derivative security
|
Direct |
64
+0.11%
|
$7,744
$121.95 P/Share
|
|
Nov 20
2019
|
Jon R Moeller Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,498
-0.44%
|
$423,258
$121.95 P/Share
|